Literature DB >> 1975387

Survival of patients with breast cancer attending Bristol Cancer Help Centre.

F S Bagenal1, D F Easton, E Harris, C E Chilvers, T J McElwain.   

Abstract

The Bristol Cancer Help Centre (BCHC) was set up in 1979 to offer various alternative therapies and treatments for patients with cancer. It attracted much public interest and a high demand for its services--and profound medical scepticism. In a study beginning in 1986 of 334 women with breast cancer attending the centre for the first time between June, 1986, and October, 1987, information about the diagnosis was obtained from case notes. Controls were a sample of 461 women with breast cancer attending a specialist cancer hospital or two district general hospitals. The same information was obtained for the control group as for the BCHC group. All patients have been followed up to June, 1988. 85% of patients with breast cancer attending the BCHC were aged under 55 at diagnosis. More than half had experienced recurrence of their disease before entry. For patients metastasis-free at entry, metastasis-free survival in the BCHC group was significantly poorer than in the controls (relapse rate ratio 2.85). Survival in relapsed cases was significantly inferior to that in the control group (hazard ratio 1.81). For cases metastasis-free at entry to the BCHC there was a significant difference in survival between cases and controls, confirming the difference in metastasis-free survival. There was no significant difference in survival or disease-free survival between the cancer hospital controls and other controls.

Entities:  

Mesh:

Year:  1990        PMID: 1975387     DOI: 10.1016/0140-6736(90)93402-b

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

Review 1.  What to do about poor clinical performance in clinical trials.

Authors:  Su Mason; Jon Nicholl; Richard Lilford
Journal:  BMJ       Date:  2002-02-16

2.  When to retract?

Authors:  Richard Smith
Journal:  BMJ       Date:  2003-10-18

3.  ATAC trial: reporting interim results is not helpful.

Authors:  Heather Goodare; Clare Dimmer; Kathy Page
Journal:  BMJ       Date:  2003-06-14

Review 4.  Evaluating prognostic factors: implications for measurement of health care outcome.

Authors:  M C Gulliford
Journal:  J Epidemiol Community Health       Date:  1992-08       Impact factor: 3.710

5.  Report on UK cancer survival rates raises questions about alternative medicine.

Authors:  C Richmond
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

6.  Psychological factors in breast cancer.

Authors:  S Lovestone; T Fahy
Journal:  BMJ       Date:  1991-05-25

7.  Whose theory is it anyway?

Authors:  Jennie Popay
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

8.  The media and cancer survival.

Authors:  Heather Goodare
Journal:  J R Soc Med       Date:  2007-10       Impact factor: 5.344

9.  The Bristol regimen for cancer patients.

Authors:  A Hoffer
Journal:  CMAJ       Date:  1991-02-15       Impact factor: 8.262

10.  Complementary and alternative medicine in patients with chronic lymphocytic leukemia.

Authors:  Manfred Hensel; Martin Zoz; Anthony D Ho
Journal:  Support Care Cancer       Date:  2008-05-06       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.